E V Makarova Selected Research

Infections

1/2023	[The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries].
9/2021	Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
1/2021	[The role of micronutrients in the comprehensive rehabilitation of patients with the novel coronavirus infection COVID-19].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E V Makarova Research Topics

Disease

3	Infections 01/2023 - 01/2021
3	COVID-19 01/2022 - 01/2021
2	Diabetes Mellitus 01/2024 - 01/2023
2	Coronavirus Infections 09/2021 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2021 - 01/2016
2	Hypertension (High Blood Pressure) 09/2021 - 01/2003
2	Type 2 Diabetes Mellitus (MODY) 09/2021 - 01/2003
1	Myocarditis (Carditis) 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Obesity 01/2023
1	Cytokine Release Syndrome 01/2023
1	Premature Aging 01/2022
1	Heart Failure 09/2021
1	Atrial Fibrillation 09/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2021
1	Osteoporosis 01/2020
1	Pain (Aches) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Hemostatic Disorders 01/2017
1	Hemorrhage 01/2017
1	Hyperglycemia 01/2016
1	Infarction (Infarctions) 01/2006
1	Hypercholesterolemia 01/2003
1	Atherosclerosis 01/2003

Drug/Important Bio-Agent (IBA)

2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 09/2021
2	VitaminsIBA 01/2021 - 01/2020
1	Insulin (Novolin)FDA Link 01/2024
1	C-Reactive ProteinIBA 01/2023
1	VildagliptinIBA 01/2023
1	Gliclazide (Diamicron)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Liraglutide FDA Link 01/2023
1	A-factor (Streptomyces)IBA 01/2022
1	AnticoagulantsIBA 09/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 09/2021
1	Prasugrel Hydrochloride FDA Link 09/2021
1	Angiotensin Receptor AntagonistsIBA 09/2021
1	Clopidogrel (Plavix)FDA Link 09/2021
1	InsulinsIBA 09/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021
1	TicagrelorIBA 09/2021
1	ZincIBA 01/2021
1	MicronutrientsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	SaltsIBA 01/2020
1	CalciumIBA 01/2020
1	ErbiumIBA 01/2017
1	Differentiation AntigensIBA 01/2016
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2016
1	Prednisolone (Predate)FDA LinkGeneric 01/2016
1	CholesterolIBA 01/2003
1	Antihypertensive Agents (Antihypertensives)IBA 01/2003

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2003
1	Self-Testing 01/2022
1	Drug Therapy (Chemotherapy) 09/2021
1	Exercise Therapy (Therapy, Exercise) 01/2019
1	Oral Surgery (Maxillofacial Surgery) 01/2017
1	Operative Surgical Procedures 01/2017
1	Lasers (Laser) 01/2017
1	Aftercare (After-Treatment) 01/2016
1	Sublingual Administration 01/2006